BUSINESS● LOW1h ago · Oct 1, 2026, 9:22 AM
Sanofi to pay Regeneron up to $8B to expand long-acting drug pipeline
Seeking Alpha Tech · global
Sanofi plans to pay Regeneron a substantial sum, reportedly up to $8 billion, to expand its pipeline for long-acting drugs. This transaction signifies a major financial investment in pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowDRC: Walter Mbonyimwami bets on AI to explore the continent's minesJeune AfriqueBUSINESS30m agoMcCormick Non-GAAP EPS of $0.86 beats by $0.10, revenue of $2.02B beats by $40MSeeking Alpha Tech